Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of ...

Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.

Wuhan YZY Biopharma Co. Ltd. is out-licensing lead candidate M-701, a CD3/EpCAM bispecific antibody, to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ) for China rights in a deal worth up to ...

The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”) are invited to the Extraordinary General Meeting (“EGM”), on Wednesday, November ...

Shares of Inventiva S.A (IVA) were rallying more than 50 percent in pre-market on Monday after the company secured 94.1 million euros ...

标准的芦荟汁，如丝般顺滑就是看着有点翻江倒海 ...

Sterling was on track on Thursday for its biggest daily fall in almost two years versus the euro and in six months against ...